Study details
Enrolling now
Cardiac Power Output in Cardiogenic Shock Patients
University of Chicago
NCT IDNCT05700617ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
5
Study length
about 3 years
Ages
18+
Locations
1 site in IL
About this study
Researchers are testing whether differences in myocardial reserve can predict outcomes for heart failure patients. The trial is designed to assess the feasibility of using invasive hemodynamics of cardiac function, representing myocardial reserve, to predict clinical outcomes for heart failure patients.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take 1:1 Randomization to receive milrinone
PhaseEARLY_Phase 1
Drug1:1 Randomization to receive milrinone
Primary goalDeath
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
CARDIOVASCULAR SYSTEM
Endpoints
Primary: Death
Body systems
Cardiology / Heart